Vaccines against human HER2 prevent mammary carcinoma in mice transgenic for human HER2. - Wikidata - awgldk - TriplyDB

Vaccines against human HER2 prevent mammary carcinoma in mice transgenic for human HER2.

Vaccines against human HER2 prevent mammary carcinoma in mice transgenic for human HER2.

http://www.wikidata.org/entity/Q37691212

about

The Promise of Preventive Cancer Vaccines Nonviral oncogenic antigens and the inflammatory signals driving early cancer development as targets for cancer immunoprevention Embryonic Lethality in Homozygous Human Her-2 Transgenic Mice Due to Disruption of the Pds5b Gene.Pathobiological implications of the d16HER2 splice variant for stemness and aggressiveness of HER2-positive breast cancer.Trial watch: Naked and vectored DNA-based anticancer vaccines Systemic delivery of HER2-retargeted oncolytic-HSV by mesenchymal stromal cells protects from lung and brain metastases.Chemo-immunotherapy induces tumor regression in a mouse model of spontaneous mammary carcinogenesis.Xenogene vaccination in the therapy of cancer.Current status of gene therapy for breast cancer: progress and challenges.Maternal Immunization: New Perspectives on Its Application Against Non-Infectious Related Diseases in Newborns.HER2 isoforms co-expression differently tunes mammary tumor phenotypes affecting onset, vasculature and therapeutic response Breast cancer vaccines delivered by dendritic cell-targeted lentivectors induce potent antitumor immune responses and protect mice from mammary tumor growth.Linking CREB function with altered metabolism in murine fibroblast-based model cell lines.Virus-like particle display of HER2 induces potent anti-cancer responses.

P2860

Q26783742-6220E10C-CB54-4DD1-8399-AE4A6E2E1A62 Q28082487-1D8E9BD3-0543-4E29-BAAD-DA2E4B3D5CE0 Q30403182-F0E9AC78-AEF5-4805-95DD-02618A980F04 Q33737058-0B38D2CE-B63F-4AA2-A1B9-A62ED67A4EB3 Q35798986-7A521599-FFAD-4FCB-9C71-661944D57A9B Q36544212-98D13529-2D65-4F67-AD10-48166F0EADB8 Q37644937-BC40BB33-CDA6-4C7C-A1AD-BABFABE01E50 Q38229368-C0F17AB5-06F5-4E82-9604-ADFEC70B02F8 Q38270806-490DFB5D-8426-4456-B869-2374A9C7E3AB Q38649517-EE51974E-3AEB-43B8-9618-EFFE5B2F65AB Q41551956-C243E9EE-D150-4E2B-A45F-E0B1BEF67A3C Q41936513-7D9D33D7-33F1-4FF8-B6EC-1AED593B773E Q47306639-AD204B68-DF44-4C4D-BBD6-FA7B7F1A693F Q52699878-4EBADE06-B73E-4458-AD02-4D0810D5C6D9

P2860

Vaccines against human HER2 prevent mammary carcinoma in mice transgenic for human HER2.

http://www.wikidata.org/entity/Q37691212

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 23 January 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Vaccines against human HER2 prevent mammary carcinoma in mice transgenic for human HER2.

@en

Vaccines against human HER2 prevent mammary carcinoma in mice transgenic for human HER2.

@nl

type

label

Vaccines against human HER2 prevent mammary carcinoma in mice transgenic for human HER2.

@en

Vaccines against human HER2 prevent mammary carcinoma in mice transgenic for human HER2.

@nl

prefLabel

Vaccines against human HER2 prevent mammary carcinoma in mice transgenic for human HER2.

@en

Vaccines against human HER2 prevent mammary carcinoma in mice transgenic for human HER2.

@nl

P1433

Q37691212-C74DD9EA-2668-4FCF-A657-82B1FB757BF6

P1476

Q37691212-B346506A-2755-48AB-ABD5-467C7C48570E

P2093

Q37691212-23172224-7A41-471B-A9EC-EDE6FC2C67A0

Q37691212-33A2B55A-FA96-4FFE-913D-6CFC9E843D56

Q37691212-35395BB9-9B0D-487D-879F-A30276247106

Q37691212-458239D3-D479-4933-8182-328D9C20C1AD

Q37691212-87F18240-EC01-4700-B2D6-B8EE316AEC9D

Q37691212-9B9BEE49-EAB2-444B-B79A-94F1FD70353E

Q37691212-AEBDFA21-524B-43FA-A951-FBEE74FB9F3E

Q37691212-CCF4F396-6580-47BD-B775-F47021F959D7

Q37691212-CE7CB7AE-135C-49AA-97C6-9B2BD30BA565

P2860

Q37691212-0AD488CB-224C-44F4-BF59-4980EB4FC4C8

Q37691212-0AE9D3B1-2653-46C9-A6C5-AA854884C026

Q37691212-1C5CE97F-EED2-4615-94D2-03045DD767E3

Q37691212-2C87E404-CA9E-42CC-AD7E-17759C47A8C2

Q37691212-36A41F89-640F-4DC4-9DCF-19DC30A49120

Q37691212-511853E7-A540-442F-B7E6-C2404B208B3B

Q37691212-5C6E98FE-5481-4BB2-9FF8-D7FAC9F52686

Q37691212-634B703B-836A-4492-AEB0-C9AA148DE77F

Q37691212-692C25B2-83B1-4536-9BC6-430F5DBC09B0

Q37691212-70120A34-4BF4-4E42-9675-9F47A19A63F9

P2888

Q37691212-C6AA6261-61D1-4F4A-9FE1-D74EB072F500

P304

Q37691212-41A55B70-DE56-4E64-BFE0-D1B4B38D02D8

P31

Q37691212-D3CEA72C-4224-4649-84AA-A77C93176EED

P356

Q37691212-2AED4FD2-8B12-41C8-8CB1-60891780DF27

P433

Q37691212-0D695AAA-696B-4E76-B27C-6EF955CDB323

P478

Q37691212-DA6F21DD-F19B-4E8F-A9FC-1969B7D2DC17

P50

Q37691212-11395FFA-917E-43B5-8F8F-C3151D93E6D7

Q37691212-14DA4BB0-4C51-4B90-8E55-1F859F1A5513

Q37691212-2F105C36-506D-4FE9-8E51-13E8E5CCFF90

Q37691212-779C3021-42B0-4E78-8DD9-A818C5ECAB9D

Q37691212-79A7CE1F-0B33-436C-B81A-38F3648AA7B7

Q37691212-7A5A837F-4813-45ED-876B-32CBB1C1B609

Q37691212-994195FE-613A-4A96-A819-D22381C2E568

Q37691212-D014B0A9-C093-4E6D-9A6D-C55470291B91

P577

Q37691212-20EBAA02-9997-4356-BB99-CD91BC9D4242

P5875

Q37691212-2BD4F45F-6A86-4B8E-8600-95EADD6FFF63

P6179

Q37691212-D1A36B2B-6653-4513-8A81-5537B9A8FC22

P698

Q37691212-95806769-9C7D-4468-9948-A101E92CD7B4

P932

Q37691212-C2A15071-690F-46E9-B446-F02D6ECD5CBF

P356

P1433

Breast Cancer Research

P1476

Vaccines against human HER2 prevent mammary carcinoma in mice transgenic for human HER2.

@en

P2093

Arianna Palladini

http://www.w3.org/2001/XMLSchema#string

Augusto Amici

http://www.w3.org/2001/XMLSchema#string

Carla De Giovanni

http://www.w3.org/2001/XMLSchema#string

Dario Ranieri

http://www.w3.org/2001/XMLSchema#string

Giordano Nicoletti

http://www.w3.org/2001/XMLSchema#string

Manuel L Penichet

http://www.w3.org/2001/XMLSchema#string

Marianna Lucia Ianzano

http://www.w3.org/2001/XMLSchema#string

Roberta Laranga

http://www.w3.org/2001/XMLSchema#string

Valentina Grosso

http://www.w3.org/2001/XMLSchema#string

P2860

Combined allogeneic tumor cell vaccination and systemic interleukin 12 prevents mammary carcinogenesis in HER-2/neu transgenic mice

EGFR/HER-targeted therapeutics in ovarian cancer

Vaccines for tumour prevention

Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease.

Multiorgan metastasis of human HER-2+ breast cancer in Rag2-/-;Il2rg-/- mice and treatment with PI3K inhibitor

Antimetastatic Activity of a Preventive Cancer Vaccine

How will human epidermal growth factor receptor 2-neu data impact clinical management of gastric cancer?

The human splice variant Δ16HER2 induces rapid tumor onset in a reporter transgenic mouse.

Vaccination with a plasmid DNA encoding HER-2/neu together with low doses of GM-CSF and IL-2 in patients with metastatic breast carcinoma: a pilot clinical trial

Anti-HER2 vaccines: new prospects for breast cancer therapy

P2888

P304

R10

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/BCR3602

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

Federica Cavallo

Pier-Luigi Lollini

Lorena Landuzzi

Massimiliano Dall'ora

P577

2014-01-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259876072

http://www.w3.org/2001/XMLSchema#string

P6179

1013492451

http://www.w3.org/2001/XMLSchema#string

P698

24451168

http://www.w3.org/2001/XMLSchema#string

P932

3979148

http://www.w3.org/2001/XMLSchema#string